Provided by Tiger Fintech (Singapore) Pte. Ltd.

Coherus BioSciences

1.06
-0.0600-5.36%
Post-market: 1.03-0.0296-2.79%17:55 EDT
Volume:1.61M
Turnover:1.70M
Market Cap:122.85M
PE:4.26
High:1.11
Open:1.09
Low:1.02
Close:1.12
Loading ...

Coherus BioSciences Reports Fourth Quarter, Full Year 2024 Financial Results and Provides Business Update

GlobeNewswire
·
11 Mar

Coherus BioSciences Inc expected to post a loss of 13 cents a share - Earnings Preview

Reuters
·
08 Mar

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
07 Mar

Coherus to Report Fourth Quarter and Full Year 2024 Financial Results on March 10, 2025

GlobeNewswire
·
03 Mar

With 59% institutional ownership, Coherus BioSciences, Inc. (NASDAQ:CHRS) is a favorite amongst the big guns

Simply Wall St.
·
27 Feb

Coherus Management to Participate at the 45th Annual TD Cowen Health Care Conference

GlobeNewswire
·
24 Feb

Coherus BioSciences, Inc. (CHRS): A Bull Case Theory

Insider Monkey
·
12 Feb

Barclays Keeps Their Buy Rating on Coherus Biosciences (CHRS)

TIPRANKS
·
27 Jan

Coherus BioSciences Price Target Maintained With a $7.00/Share by HC Wainwright & Co.

Dow Jones
·
23 Jan

Coherus Presents Final Phase 2 Clinical Casdozokitug Combination Data in Patients with Metastatic Hepatocellular Carcinoma at ASCO-GI 2025

GlobeNewswire
·
22 Jan

Coherus BioSciences Inc - FY 2024 Preliminary Net Revenues Expected to Be $255M-$260M

THOMSON REUTERS
·
14 Jan

Coherus Management to Present at the 43rd Annual J.P. Morgan Healthcare Conference

GlobeNewswire
·
08 Jan

Coherus to Present Final Phase 2 Casdozokitug Combination Data in Patients with Metastatic Hepatocellular Carcinoma at ASCO-GI 2025

GlobeNewswire
·
18 Dec 2024

Coherus BioSciences Price Target Maintained With a $7.00/Share by HC Wainwright & Co.

Dow Jones
·
04 Dec 2024

Coherus Biosciences price target lowered to $7 from $12 at H.C. Wainwright

TIPRANKS
·
04 Dec 2024

Unusually active option classes on open December 3rd

TIPRANKS
·
03 Dec 2024

Coherus BioSciences Shares up 42% on Deal to Divest Biosimilar of Amgen's Neulasta

THOMSON REUTERS
·
03 Dec 2024

Sector Update: Health Care Stocks Decline Premarket Tuesday

MT Newswires Live
·
03 Dec 2024

Morning Movers: U.S. Steel falls following Trump vow to block Nippon deal

TIPRANKS
·
03 Dec 2024

BUZZ-Coherus Bio jumps on deal to divest biosimilar of Amgen's Neulasta

Reuters
·
03 Dec 2024